The Role of End-of-Life Issues in the Design and Reporting of Cancer Clinical Trials: A Structured Literature Review
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of End-of-Life Issues in the Design and Reporting of Cancer Clinical Trials: A Structured Literature Review
Authors
Keywords
Cancer treatment, Lung and intrathoracic tumors, Pancreatic cancer, Melanomas, Glioblastoma multiforme, Palliative care, Clinical trials (cancer treatment), Scientific publishing
Journal
PLoS One
Volume 10, Issue 9, Pages e0136640
Publisher
Public Library of Science (PLoS)
Online
2015-09-02
DOI
10.1371/journal.pone.0136640
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Palliative Care
- (2017) Michael H. Levy et al. Journal of the National Comprehensive Cancer Network
- Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports
- (2015) M. Kohler et al. BMJ-British Medical Journal
- Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports
- (2015) M. Kohler et al. BMJ-British Medical Journal
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2013) David Moher ANNALS OF INTERNAL MEDICINE
- Reporting of Patient-Reported Outcomes in Randomized Trials
- (2013) Melanie Calvert et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reporting Trends of Outcome Measures in Phase II and Phase III Trials Conducted in Advanced-Stage Non-small-cell Lung Cancer
- (2013) Saurav Ghimire et al. LUNG
- Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany
- (2013) Shrividya Iyer et al. LUNG CANCER
- "Well, I Think There Is Great Variation...": A Qualitative Study of Oncologists' Experiences and Views Regarding Medical Criteria and Other Factors Relevant to Treatment Decisions in Advanced Cancer
- (2013) J. Schildmann et al. ONCOLOGIST
- Priorities for treatment, care and information if faced with serious illness: A comparative population-based survey in seven European countries
- (2013) Irene J Higginson et al. PALLIATIVE MEDICINE
- ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research
- (2013) Bryce B. Reeve et al. QUALITY OF LIFE RESEARCH
- The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study
- (2013) Shrividya Iyer et al. SUPPORTIVE CARE IN CANCER
- Efficacy, Patient-Reported Outcomes (PROs), and Tolerability of the Changing Therapeutic Landscape in Patients with Metastatic Prostate Cancer (MPC): A Systematic Literature Review
- (2013) Brian S. Seal et al. VALUE IN HEALTH
- Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals
- (2013) Carolina Riveros et al. PLOS MEDICINE
- Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: A systematic review
- (2012) Cecilie Delphin Amdal et al. ACTA ONCOLOGICA
- A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study
- (2012) Y Nakai et al. BRITISH JOURNAL OF CANCER
- Recommendations for including multiple symptoms as endpoints in cancer clinical trials
- (2012) Charles S. Cleeland et al. CANCER
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
- (2012) Roger Stupp et al. EUROPEAN JOURNAL OF CANCER
- Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology
- (2012) Ethan Basch et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care
- (2012) Thomas J. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study
- (2012) Tudor Ciuleanu et al. LANCET ONCOLOGY
- The Use of Patient-reported Outcomes (PRO) Within Comparative Effectiveness Research
- (2012) Sara Ahmed et al. MEDICAL CARE
- Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
- (2011) Mark R. Gilbert et al. JOURNAL OF NEURO-ONCOLOGY
- Best Supportive Care: A Euphemism for No Care or a Standard of Good Care?
- (2011) Nathan Cherny SEMINARS IN ONCOLOGY
- Symptom burden and performance status in a population-based cohort of ambulatory cancer patients
- (2010) Lisa Barbera et al. CANCER
- Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study
- (2010) Giuseppe Colucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
- (2010) Wolfgang Wick et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy
- (2010) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial
- (2010) Il Han Kim et al. JOURNAL OF NEURO-ONCOLOGY
- The needs of patients with advanced, incurable cancer
- (2009) K Rainbird et al. BRITISH JOURNAL OF CANCER
- A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer
- (2009) C Yoo et al. BRITISH JOURNAL OF CANCER
- Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma: A Report From the 11715 Study Group
- (2008) David F. McDermott et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
- (2008) David A. Reardon et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More